טוען...
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
Glucagon-like peptide 1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are medications used for managing diabetes, mimicking the metabolic effects of incretin hormones. Recent evidence suggests that these medications have antioxidative potentials in the diabetic milieu. The pathophysiology...
שמור ב:
| הוצא לאור ב: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099522/ https://ncbi.nlm.nih.gov/pubmed/34007411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9959320 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|